Immunometabolism refers to the modifications in immune cells' internal metabolic pathways that occur when they are activated. In recent years, a slew of discoveries has been made in the field of immunometabolism, which refers to changes in immune cells' internal metabolic pathways that modify their activity. Immunometabolism opens up new avenues for drug development in immune-related disorders. The ability to change the actions of macrophages in situ requires interconnection between certain metabolic components and immunological signalling pathways. Immunometabolism has emerged as a key regulator of both adaptive and innate immunity. It was evident from the beginning that metabolism and the immune system are intimately intertwined. Inflammatory cytokines were generated in obese adipose tissue, and these cytokines led to metabolic illness. Immunometabolism is a rapidly developing field of research, with a second research wave arising from cancer metabolism studies to explore the intrinsic metabolic pathways of immune cells themselves and how those pathways influence cell destiny and function. The field is driven by a few core ideas and goals.
Title : The severity of COVID-19 shifts the cytokine and chemokine milieu toward the proinflammatory environment
Mohamed Labib Salem, Tanta University, Egypt
Title : Kaposi Sarcoma Associated Immune Reconstitution Inflammatory Syndrome (Ks-Iris) – Recognition And Treatment In The Age of Advancing Antiretroviral Therapy
Alec Bigness, University of South Florida Morsani College of Medicine, United States
Title : Treg-specific IL-2 therapy can reestablish intrahepatic immune regulation in autoimmune hepatitis
Laura Elisa Buitrago Molina, Hannover Medical School, Germany
Title : Regulatory T cells with chimeric antigen receptors as treatment for autoimmunity
Matthias Hardtke Wolenski, Hannover Medical School, Germany